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The	 work	 here	 describes	 the	 synthesis	 of	 tailor-made,	 porous,	 polymeric	materials	 with	 elastic	
moduli	 in	 the	 range	associated	with	mammalian	brain	 tissue	 (0.1-24	kPa).	 Three	new	emulsion-
templated	 porous	 polymer	 materials	 (polyHIPEs)	 were	 synthesised	 by	 thiol-ene	
photopolymerisation	 from	 hexanediol	 diacrylate	 (HDDA)	 and	 polyethylene	 glycol	 diacrylate	
(PEGDA)	 crosslinkers	 and	 compared	 with	 a	 previously	 reported	 material	 prepared	 from	




at	 37°C.	 PEGDA	 crosslinked	 materials	 had	 improved	 visible	 light	 transmission	 properties	 when	
compared	 to	 TMPTA	 crosslinked	 materials	 under	 a	 bright	 field	 microscope.	 All	 materials	 were	
shown	via	hematoxylin	and	eosin	 staining	 to	 support	 the	 infiltration	and	attachment	of	 induced	
pluripotent	stem	cell	(iPSC)-derived	human	neural	progenitor	cells	(hNPCs).	HNPCs	on	all	materials	
were	 demonstrated	 in	 short	 term	 3D	 cultures	 to	 maintain	 a	 phenotype	 consistent	 with	 early	




The	 human	 brain	 is	 the	 most	 complex	 and	 least	 understood	 organ	 of	 the	 human	 body.	 Key	
challenges	 for	 researchers,	 given	 rapidly	 aging	populations	 in	developed	 countries,	 are	not	only	
understanding	 how	 neurological	 diseases	 develop,	 but	 also	 how	 to	 stop	 their	 progression.	 A	
plethora	of	neurological	disorders	and	diseases	exist,	yet	little	to	no	cures	are	apparent	for	many	
of	 these	 conditions.	 The	 limited	 access	 to	 live	 human	 neural	 tissue,1	 along	with	 physiologically	
inaccurate	 2D	 cell	 cultures2	 and	 questionably	 valid	 mouse	models3,	 4	 have	 made	 it	 difficult	 for	
researchers	 to	 study	 the	 human	brain	 and	 human	neurological	 disorders.	 Advances	 in	 this	 field	
require	new	tools	with	which	to	recreate	human	neural	tissue	in	vitro,	and	produce	representative,	
healthy	 tissue	 and	 disease	models,	 for	 the	 study	 of	 neurological	 diseases	 and	 new	 therapeutic	
targets.	
	
3D	 cell	 culture	 and	 tissue	 engineering	 techniques	 aim	 to	 produce	 cells	 and	 tissue	 that	 are	
physiologically	 comparable	 to	 those	 found	 in	 vivo.	 Cells	 receive	 a	 variety	 of	 cues	 from	 their	











deliver	 specific	 extracellular	 cues	 typically	 in	 the	 form	 of	 cell-cell	 interactions,	 cell-factor	
interactions	 and	 cell-matrix	 interactions.	 Through	 these	 interactions	 the	 stem	 cell	 niche	 can	
support	the	self-renewal	of	stems	cells	as	well	as	trigger	the	specific	linage	commitment	of	stem	
cells.7	 The	 neural	 stem	 cell	 niche	 is	 located	 primarily	 in	 the	 sub	 ventricular	 zone	 of	 the	 human	
brain,	and	provides	the	specific	set	of	conditions	for	the	maintenance	of	neural	stem	cells	and	the	
commitment	 of	 neural	 stem	 cells	 to	 neuronal	 and	 glial	 cell	 lineages	 for	 the	 growth	 of	 neural	
tissue.8	The	neural	stem	cell	niche-ECM	is	comprised	of	a	hyaluronic	acid	back	bone9	and	proteins	
laminin,	 fibronectin,	 proteoglycans	 and	 other	 molecules.10	 When	 designing	 advanced	 in	 vitro	
environments	 for	 the	 creation	 of	 stem	 cell-derived	 tissue	 it	 is	 important	 to	 take	 design	
characteristics	from	the	stem	cell	niche	as	much	as	possible.11	
	
Access	 to	 live,	 developing	 human	 neural	 tissue	 is	 extremely	 limited	 due	 to	 the	 sensitivity	 and	
accessibility	 of	 the	 brain,	 therefore	 current	 research	 techniques	 take	 advantage	 of	 human	
pluripotent	stem	cells	(hPSCs)	and	subsequent	directed	differentiation	techniques.	HPSCs	obtained	
from	 human	 embryos,12	 human	 embryonic	 stem	 cells	 (hESCs),	 or	 derived	 from	 somatic	 cells,13	
induced	 pluripotent	 stem	 cells	 (iPSCs),	 have	 the	 ability	 to	 differentiate	 to	 all	 cell	 types	 in	 the	
human	body.	By	specifically	controlling	in	vitro	environments,	hPSC	differentiation	can	be	directed	
toward	 certain	 cell	 lineages	 to	 produce	 a	 variety	 of	 cell	 types.	 Human	 neural	 progenitor	 cells	
(hNPCs)	 can	 be	 quickly	 and	 efficiently	 generated	 from	 hPSCs	 via	 single14-16	 and	 dual	 SMAD	




It	 is	 important	 for	tissue	engineering	scaffolds	to	mimic	the	mechanical	properties	of	 the	tissue-
type	of	interest.	The	mechanical	properties	of	mammalian	brain	tissue	have	been	widely	studied	




methods,	 test	 conditions	 and	 species,	 as	 well	 as	 on	 age	 and	 development.	 	 When	 designing	
materials	 for	neural	 tissue	engineering	 it	 is	 important	 that	 their	elastic	modulus	 falls	within	 this	
range.	Scaffold	stiffness	has	been	shown	to	affect	the	ability	of	mouse	embryonic	and	rat	neural	






as	allowing	cells	 to	 freely	migrate	 throughout	 the	structure	with	 limited	 resistance.	Polymerised	
high	 internal	 phase	 emulsions	 (PolyHIPEs)	 are	 a	 class	 of	 solid	 porous	 material	 that	 have	 been	
shown	to	be	effective	as	tissue	engineering	scaffolds.29,	33-44	They	are	produced	by	a	process	called	




interconnected	 voids.	 In	 most	 cases,	 polyHIPEs	 are	 produced	 via	 thermally	 initiated	 radical	
polymerisation	reactions.	However,	these	reactions	are	relatively	slow	and	require	emulsions	that	
	 6	
are	 sufficiently	 stable	 at	 polymerisation	 temperature	 (typically	 50-70	 oC),	 ruling	 out	 the	 use	 of	
certain	monomers.	More	 recently,	 photoinitiated	 thiol-ene	 click-chemistry	 reactions	 have	 been	
used	 to	 polymerise	 emulsions	 that	 lack	 long-term	 stability.39,	 49,	 50	 This	 broadens	 the	 range	 of	
monomers	 that	 can	 potentially	 be	 used	 for	 the	 synthesis	 of	 polyHIPE	 materials,	 in	 particular	
allowing	the	use	of	monomers	that	do	not	lead	to	highly	stable	emulsions.	
	
The	work	 presented	 here	 investigates	 the	 creation	 of	 thiol-ene	 polyHIPE	materials	 with	 similar	
mechanical	properties	to	that	of	mammalian	brain	tissue.	The	methods	employed	include	reducing	
the	 crosslink	 density	 of	 the	network	polymer,	 increasing	 the	distance	between	 crosslinks	 in	 the	
network	 and	 increasing	 the	 overall	 porosity	 of	 the	 material.	 The	 mechanical	 properties	 of	 the	
materials	produced	were	determined	in	tensile	mode.	The	ability	of	materials	to	absorb	medium	






Trimethylolpropane	 triacrylate	 (TMPTA),	 trimethylolpropane	 tris(3-mercaptopropionate)	
(TMPTMP),	 1,6-hexanediol	 diacrylate	 (HDDA),	 poly(ethylene	 glycol)	 diacrylate	Mn=700	 (PEGDA),	
diphenyl(2,4,6-trimethylbenzoyl)phosphine	 oxide/2-hydroxy-2-methylpropiophenone	 blend	
(photointiator),	phosphate	buffered	saline	(PBS),	1,2-dichloroethane	and	laminin	from	Engelbreth-
Holm-Swarm	 murine	 sarcoma	 basement	 membrane	 were	 all	 purchased	 from	 Sigma-Aldrich.	
AggreWellTM800	plates,	NeurocultTM	NS-A	Basal	Medium	(Human),	NeurocultTM	NS-A	Proliferation	
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Supplement,	 STEMdiffTM	 Neural	 Progenitor	 Medium	 (STEMdiff	 NPM),	 STEMdiffTM	 Neural	
Progenitor	 Freezing	Medium	 (STEMdiff	 NPM	 Freeze	Medium)	 and	 Y-27632	 RHO/ROCK	 inhibitor	
were	 obtained	 from	 STEMCELL	 Technologies.	 Essential	 8TM	 Medium,	 Geltrex	 LDEV-Free	 hESC-
Qualified	 Reduced	 Growth	 Factor	 Basement	 Membrane	 Matrix,	 EDTA	 (0.5M)	 pH	 8.0,	 TrypLETM	
Express	 Enzyme	 (1X),	 DMEM/F12	 (Ham)	 (1:1)	 +	 GlutaMAXTM-I	 (1X)	 supplement	 (DMEM/F12),	
StemPro®	Accutase®	Cell	Dissociation	Reagent,	Trypan	Blue	Stain,	Goat	anti-Rabbit	IgG	(H+L)	Alexa	
Fluor®	 568,	 4’,6-Diamidino-2-Phenylindole,	 Dihydrchloride	 (DAPI),	 NuncTM	 Lab-TekTM	 II	 8-well	
Chamber	 SlidesTM	 and	 Dulbecco’s	 phosphate	 buffered	 saline	 without	 calcium	 and	 magnesium	
(DPBS)	were	all	purchased	from	Life	Technologies	Australia	Pty	Ltd.	HYPERMERTM	B-246SF-LQ-(AP)	
was	 obtained	 from	 Croda.	 3CB2	 Anti-Vimentin	 IgM	 mouse	 antibody	 was	 purchased	 from	
Developmental	Studies	Hybridoma	Bank.	Recombinant	human	basic	FGF	(bFGF)	and	recombinant	
human	 EGF	 were	 purchased	 from	 PeproTech.	 Corning®	 Costar®	 Ultralow	 attachment	 multiwell	
















and	 belt	 speed	 of	 3.2	m/min.	 The	 resulting	 polyHIPE	 was	 washed	 in	 an	 immersion	 of	 acetone	
overnight.	The	polyHIPE	was	further	washed	by	Soxhlet	extraction	using	dichloromethane	for	24	
hours.	The	polyHIPE	was	air	dried	overnight	then	vacuum	dried	for	24	hours	at	room	temperature.	
PolyHIPE	materials	produced	by	this	method	are	known	to	contain	residual	 thiols	 resulting	 from	










PolyHIPE	 structure	 was	 analysed	 using	 an	 FEI	 Nova	 NanoSEM	 450	 FEGSEM	 operating	 at	 5	 kV.	























saline	 at	 37°C	 using	 a	 Bose	 Electroforce	 3200	 II	 in	 situ	 biomechanical	 tester	 with	 WinTest®	 7	
software.	 Samples	 were	 placed	 in	 a	 chamber	 of	 PBS	 recirculating	 at	 37°C.	 Samples	 were	 then	






The	 elastic	modulus	was	 deduced	 from	 these	 curves	 using	 a	method	 described	 by	 Kendall	 and	
Fuller.53	Briefly,	the	data	was	fit	with	the	following	power	equation	(Equation	2):	







different	 time	 intervals	 samples	 were	 removed	 from	 solution.	 The	 wet	 weight	 (mw)	 was	
immediately	measured.	Samples	were	then	pressed	between	two	pieces	of	paper	towel	to	vacate	
any	 PBS	 in	 pores	 and	 swollen	 weight	 (msw)	 was	 then	 determined.	 Two	 calculations	 were	
performed	(Equations	3-4):	
	
𝐹𝑙𝑢𝑖𝑑 𝑢𝑝𝑡𝑎𝑘𝑒 𝑜𝑓 𝑤ℎ𝑜𝑙𝑒 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (%) = !!!!!!! ×100	 	 	 [3]	
	





placed	 in	 15	 ml	 of	 PBS	 in	 TeflonTM	 capped	 vials	 at	 37°C	 on	 orbital	 rotation	 at	 70	 rpm.	 After	
different	time	intervals	up	to	77	days,	samples	were	removed	from	solution,	washed	three	times	









Research	 (2007,	updated	2015),	 the	Australian	Code	of	Responsible	Conduct	of	Research	 (2007)	
and	with	approvals	from	Monash	University	and	the	CSIRO	Human	Research	Ethics	Offices.	
	
The	 iPS	 cell	 line	 HDF51i-509,	 previously	 derived	 by	 Sendai	 reprogramming	 of	 human	 dermal	
fibroblast	 (HDF)	cells,54	was	kindly	provided	under	materials	 transfer	agreement	by	Prof.	 Jeanne	
Loring	(The	Scripps	Research	Institute,	CA,	USA).	HDF51i-509	hiPSCs	were	maintained	in	Essential	




in	 serum-free	 culture	 via	 the	 initial	 formation	 of	 uniform-sized	 cell	 aggregate	 embryoid	 bodies	
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(EBs),56	 with	 neural	 lineage	 induction	 by	 bone	 morphogenic	 protein	 (BMP)	 inhibition	 in	
neurosphere	 suspension	 culture	 and	 subsequent	 monolayer	 mitogen	 expansion	 of	 generated	
NPCs.14-16,	57,	58	Briefly,	hiPSCs	harvested	from	E8	maintenance	culture	with	Accutase	were	seeded	
in	 AggreWellTM800	 plates	 at	 10,000	 cells/microwell	 (STEMCELL	 Technologies,	 as	 per	
manufacturer’s	 protocol)	 in	 serum-free	 NeuroCultTM	 NS-A	 human	 Basal	 Medium	 supplemented	
with	NeuroCultTM	NS-A	human	Proliferation	Supplement,	20	ng/µl	recombinant	human	bFGF	and	
20	 ng/µl	 recombinant	 human	 EGF,	 (Complete	 NeuroCult	 NS-A	 Proliferation	 medium),	 with	 the	
addition	 of	 500	 ng/ml	 human	 noggin	 and	 10	 µM	 ROCK	 inhibitor	 Y-27632.59	 AggreWell	 cultures	






Neurospheres	 were	 mechanically	 dissociated	 using	 TrypLE	 Express	 with	 15-20	 minute/37°C	
incubations	and	cells	seeded	at	5x104/cm2	onto	tissue	culture	wells	coated	with	laminin	(10	µg/ml	
in	 DMEM/F12,	 coating	 1	 µg/cm2)	 in	 Complete	 NeuroCult	 NS-A	 Proliferation	 to	 generate	 an	
adherent	monolayer	 culture	 of	 neural	 precursor	 cells.	NPCs	were	 passaged	 at	 ~80%	 confluence	
each	 4-7	 days	 using	 Accutase,	 replating	 at	 ~5-10x104	 cells/cm2	 and	 transferring	 renewing	 stem	
cells	 to	 STEMdiff	 NPM	 from	 the	 third	 passage,	 with	 media	 changes	 each	 second	 day	 (as	 per	
STEMdiff	Neural	System	protocols,	STEMCELL	Technologies).	An	established	HDF51-509i	NPC	line	
was	 successfully	maintained	 for	up	 to	15	passages	 in	 STEMdiff	NPM,	 cryopreserved	 in	 STEMdiff	
NPM	 Freeze	 Medium	 and	 thawed	 as	 an	 expanding	 population	 of	 NPCs,	 validated	 by	





3D	 hNPC	 culture	 on	 scaffolds:	 circular	 disk	 scaffolds	 of	 15	mm	diameter	 and	 200	 µm	 thickness	
were	 cut	 from	 a	 cylinder	 of	 polyHIPE	 by	 sectioning	 using	 a	 Leica	 VT100	 S	 vibrating-blade	
microtome.	 Samples	 too	 soft	 to	 section	 with	 a	 vibratome	were	 embedded	 in	 optimum	 cutting	
temperature	 (OCT)	 medium	 and	 sectioned	 using	 a	 Leica	 CM3050-S	 Cryostat.	 Disks	 were	 then	












Fixed	 scaffolds	were	 processed	 to	 remove	water	 and	 infiltrate	with	wax.	 Samples	 underwent	 a	
four	hour	 formalin	processing	program	of	80%	ethanol,	 xylene	 then	paraffin	on	a	Leica	PELORIS	
Tissue	Processor.	Processed	scaffolds	were	then	embedded	 in	paraffin	wax	and	sectioned	 into	4	
μm	 slices	 using	 a	 Rotary	 Microtome	 CUT	 4060	 (microTEC).	 Sections	 were	 then	 mounted	 on	
polylysine	 slides	 (Thermo	 Scientific)	 and	 air-dried	 overnight	 at	 room	 temperature.	 To	 stain,	
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samples	were	dewaxed	in	xylene	and	washed	with	ethanol	and	water.	Samples	were	then	stained	
in	Harris’s	Haematoxylin	 for	5	min.	Samples	were	 then	washed	with	water,	quickly	 immersed	 in	
acid	 alcohol	 and	 again	washed	with	water	 before	 counterstaining	with	 Eosin	 for	 5	min.	 Stained	
sections	were	then	washed	with	ethanol,	dehydrated	with	xylene	and	cover	slipped.	Samples	were	




For	 immunocytochemical	 staining,	 sections	 were	 prepared	 as	 described	 above.	 Sections	
underwent	 heat	 induced	 epitope	 retrieval	 at	 98°C	 for	 30	 minutes	 in	 a	 Dako	 Target	 Retrieval	
Solution,	 citrate	 pH	 6	 solution	 on	 a	Dako	 PT	 Link	 Rinse	 Station.	HNPCs	 cultured	 on	 8-well	 glass	
chamber	 slides	 were	 fixed	 using	 4%	 formaldehyde	 in	 PBS	 and	 did	 not	 undergo	 the	 epitope	
retrieval	process.	Samples	were	incubated	with	blocking	buffer,	10%	v/v	normal	goat	serum	in	PBS	
(blocking	buffer),	for	1	hour	at	room	temperature	then	incubated	in	4.4	μg/mL	3CB2	Anti-Vimentin	
IgM	mouse	primary	 antibody	 in	blocking	buffer	 for	 1	hour	 at	 room	 temperature.	 Samples	were	
then	washed	 three	 times	 in	 PBS	 for	 5	minutes	 each	with	 agitation	 then	 incubated	 in	 goat	 anti-
rabbit	 IgG	 (H+L)	Alexa	Fluor®	568	 secondary	antibody	 (4	μg/mL	 (1:500)	 in	blocking	buffer)	 for	1	
hour	at	room	temperature.	Samples	were	subsequently	washed	three	times	in	PBS	for	5	minutes	
each	with	agitation,	then	counterstained	with	DAPI	(2	μg/ml	or	1:500)	and	incubated	for	5	minutes	







The	 monomer	 trimethylolpropane	 tris(3-mercaptopropionate)	 (trithiol)	 was	 reacted	 with	 three	
different	 multifunctional	 acrylate	 crosslinkers:	 trimethylolpropane	 triacrylate	 (TMPTA),	 1,6-
hexanediol	diacrylate	(HDDA)	and	poly(ethylene	glycol)	diacrylate	(PEGDA)	to	produce	materials	of	
varying	 cross-linking	 density	 and	 mechanical	 properties.	 In	 an	 attempt	 to	 reduce	 the	 elastic	
modulus	 of	 the	 materials	 to	 that	 of	 mammalian	 brain	 tissue,	 three	 approaches	 were	 taken:	
reducing	 the	 crosslink	 density,	 increasing	 the	 physical	 length	 of	 crosslinks	 and	 increasing	 the	
porosity	of	the	material.	
	
TMPTA	 polyHIPEs	 were	 successfully	 produced	 using	 conditions	 previously	 reported	 (Figure	 2A,	
Table	S1).39	Attempts	to	use	the	same	set	of	conditions	with	the	HDDA	monomer	gave	an	unstable	
emulsion,	possibly	due	to	the	reduction	in	external	phase	viscosity.	Stirrer	speed	was	increased	to	
470	 rpm,	 to	 reduce	 internal	 phase	 droplet	 size	 and	 give	 a	 HIPE	 of	 good	 stability	 that	was	 able	
polymerise	(Figure	2B).	PolyHIPE	then	made	with	the	PEGDA	monomer	under	the	original	TMPTA	
conditions	 formed	 a	 highly	 stable,	 highly	 viscous	 HIPE.	 Whilst	 very	 stable	 this	 HIPE	 would	 not	
polymerise	under	UV	 light,	possibly	due	to	monomer	density	reducing	 light	penetration	 into	the	
HIPE,	preventing	polymerisation.	Lowering	the	monomer	concentration	in	the	organic	phase	to	0.5	
M	gave	an	unstable	emulsion.	A	monomer	concentration	of	0.79	M	 in	 the	organic	phase	gave	a	









All	materials	were	 observed	 by	 SEM	 to	 have	 a	 porous	 structure	 as	 a	 result	 of	 vacated	 internal	
phase	 water	 droplets	 (Figure	 2A-D).	 An	 interconnected	 porous	 network	 is	 created	 by	 internal	
phase	droplets	coming	into	contact	with	adjacent	droplets,	and	can	be	seen	in	all	materials.	Some	
defects	 can	 be	 seen	 in	 the	 materials	 made	 with	 the	 PEGDA	 monomer	 (Figure	 2C	 and	 D),	
particularly	in	the	thin	sections	between	interconnects.	This	can	possibly	be	a	result	of	strain	put	










(A),	 HDDA	 crosslinker	 at	 80%	 porosity	 (B),	 PEGDA	 crosslinker	 at	 80%	 porosity	 (C)	 and	 PEGDA	
crosslinker	at	85%	porosity	(D).	(Scale	bar	=	100	μm)	
	
SEM	 images	 were	 analysed	 using	 Image	 J	 imaging	 software	 to	 determine	 pore	 diameter	
distributions	 (Figure	 S1)	 and	 averages	 (Table	 S2).	 	 A	 pore	 diameter	 between	 20-70	 μm	 has	





monomer.	The	PEGDA	polyHIPEs	also	had	 increased	average	pore	diameters	at	 the	 same	stirrer	















Once	 synthesised,	 the	 polyHIPEs,	 in	 particular	 the	 PEGDA	 materials,	 were	 observed	 to	 swell	





Figure	 3.	 PBS	 uptake	 profiles	 of	 the	 scaffold	 material	 as	 a	 whole	 (A)	 and	 solely	 the	 scaffold	
polymer	phase	(B)	(N=3,	mean	±	standard	deviation)	
	
All	 materials	 were	 expected	 to	 take	 up	 a	 certain	 amount	 of	 PBS	 due	 to	 their	 interconnected	
porous	structure.	Both	TMPTA-	and	HDDA-based	materials	reached	an	equilibrium	PBS	uptake	of	
around	100%	of	their	weight	after	approximately	10	minutes	(Figure	3A).	The	80%	porous	PEGDA	
material	 was	 found	 to	 absorb	 more	 than	 seven	 times	 its	 own	 weight	 in	 PBS	 after	 10	 minutes	
swelling.	The	highly	absorbing	capacity	of	the	PEGDA	crosslinked	materials	is	most	likely	due	to	the	




















































These	 results	 indicate	 that	 the	 PEGDA-crosslinked	 polyHIPEs	 display	 hydrogel-like	 properties	 in	
terms	 of	 their	 ability	 to	 absorb	 water.	 The	 PEGDA	 polyHIPE	 displays	 the	 characteristic	 of	 a	
hierarchical	 porosity,	 with	 pores	 due	 to	 the	 emulsion	 templating	 process	 and	 smaller	 pores	
present	 in	 the	 solid	material	 itself	which	 are	 able	 to	 absorb	water.	 An	 ability	 to	 absorb	 a	 large	
amount	of	water	translates	into	a	better	material	environment	for	cell	culture.		Materials	that	can	









far	more	 transparent	 than	both	 the	TMPTA-	and	HDDA-crosslinked	materials.	As	 can	be	 seen	 in	
Figure	4A	the	PEGDA	polyHIPEs	are	visibly	more	transparent	than	those	for	TMPTA.	Further,	under	













materials.	 PolyHIPE	 samples	 were	 produced	 as	 sheets	 of	 approximately	 3	 mm	 thickness,	 from	
which	 dog	 bone-shaped	 samples	 were	 stamped	 out	 using	 an	 ASTMD638	 Type	 V	 die.	 	 All	 four	
materials	 were	 first	 tested	 in	 a	 completely	 dry	 state.	 Samples	 were	 extended	 uniaxially	 at	 a	







hypothesised,	 substituting	 the	 trifunctional	 crosslinker	 for	 a	 difunctional	 crosslinker	 produced	 a	







porosity	of	 the	PEGDA	polyHIPE	 from	80	 to	85%	produced	no	significant	change	 in	 the	strain	at	
break,	but	did	however	give	a	drop	in	the	stress	at	break	to	99	kPa	and,	more	importantly,	a	drop	
in	the	elastic	modulus	to	13	kPa.	As	previously	mentioned,	the	elastic	modulus	of	the	mammalian	








TMPTA_80%	 250±8.6	 220±15	 68±1.7	
HDDA_80%	 290±66	 100±28	 27±3.2	
PEGDA_80%	 730±60	 220±21	 24±1.1	





PBS	at	37°C	to	mimic	 in	vivo	conditions.	Due	to	the	extension	 limitations	of	the	apparatus,	 tests	
could	 not	 be	 performed	 to	 break.	 Only	 elastic	 modulus	 values	 were	 obtained	 from	 the	 stress-





Figure	 5.	 	 Comparison	 of	 elastic	modulus	 of	 PEGDA	 based	 polyHIPEs	 under	 dry	 conditions	 and	
mimicked	biological	conditions	swollen	(S)	in	PBS	at	37°C	(N=6,	mean	±	standard	deviation)	
	
A	 significant	 reduction	 in	modulus	was	 observed	 for	 both	 80	 and	 85%	 porous	 PEGDA	 polyHIPE	
materials	when	tested	swollen	under	mimicked	biological	conditions	(Figure	5).		When	swollen,	a	
given	volume	of	PEGDA	polyHIPE	contains	less	polymeric	material	then	the	same	given	volume	in	



































shown	to	decrease	 in	 the	swollen	state.	Both	80	and	85%	PEGDA	materials	 in	 the	swollen	state	
display	elastic	modulus	values	 in	 the	 range	 reported	 for	 that	of	mammalian	brain	 tissue	at	18.4	





synthesis	 to	 take	 over	 can	 greatly	 enhance	 its	 ability	 to	 produce	 tissue	 that	 more	 accurately	
represents	that	found	in	vivo.	It	was	hypothesised	that	these	thiol-ene	materials	could	degrade	via	
ester	 hydrolysis.	Materials	were	 placed	 in	 PBS	 at	 37°C	 and	 their	 change	 in	mass	 over	 time	was	







conditions.	Despite	having	 the	same	concentration	of	ester	 linkages	as	 the	TMPTA	material,	 the	
HDDA	material	 in	theory	has	a	lower	cross-link	density	giving	it	 less	impeded	access	for	water	to	
attack	the	ester	groups.	The	TMPTA	material	displayed	a	significantly	slower	degradation	rate	than	
both	 the	 HDDA	 and	 PEGDA	materials	 under	 accelerated	 conditions.	 The	 TMPTA	material	 is	 the	





Figure	 6.	 Materials	 degradation	 experiments.	 Degradation	 under	 mimicked	 physiological	
conditions	 in	 PBS	 at	 37°C	 (A)	 and	 under	 accelerated	 conditions	 in	 0.1M	 NaOH	 at	 room	
temperature	(B).	(N=3,	mean	±	standard	deviation)	
	










































































laminin-coated	 scaffold	 materials	 TMPTA	 (A),	 HDDA	 (B),	 PEGDA_85%	 (C),	 PEGDA_80%	 (D)	 and	
Alvetex®	control	(E)	stained	with	hematoxylin	and	eosin.	(Scale	bar	=	200	μm)	
	
By	 H&E	 staining,	 NPCs	 were	 observed	 to	 be	 distributed	 throughout	 each	 of	 the	 five	 materials	
(Figure	7A-E).	All	sections	of	polyHIPE	materials	displayed	cell	densities	comparable	to	that	for	the	



















To	demonstrate	a	phenotypic	 identity	 for	 the	 iPSC-derived	hNPCs	cultured	within	 these	scaffold	
materials,	cells	were	immunostained	to	detect	the	expression	of	vimentin,	a	type	III	intermediate	
filament	protein63	that	contributes	to	the	filamentous	network	of	the	cell	cytoskeleton.64	Vimentin	
is	 found	 in	 the	 radial	 glial	 cells	 that	 arise	 from	 the	 primitive	 neuroepithelial	 lineage	 of	 the	
developing	CNS	and	give	 rise	both	 in	vivo	and	 in	vitro	 from	the	early	differentiation	of	hPSCs	 to	








3D	scaffold	 cultures.	Background	blue	 staining	arises	 from	scaffold	autofluorescence	 in	 the	blue	
channel	(Figure	S3).	All	scaffold	materials	display	potential	for	longer	term	cultures	to	support	the	









significantly	 improved	 light	transmission	abilities,	beneficial	 for	cell	culture	 imaging.	PEGDA_80%	
materials	 showed	3.8%	degradation	after	11	week	 incubation	 in	mimicked	biological	 conditions.	
The	 same	material	 also	 displayed	 full	 degradation	 under	 accelerated	 conditions	 in	 0.1	M	NaOH	
after	 30	 minutes.	 After	 3	 days	 culture	 with	 iPSC-derived	 human	 neural	 progenitor	 cells,	 all	
materials	presented	 in	 this	work	displayed	the	presence	of	hNPCs	that	appear	 to	have	migrated	
throughout	 the	 scaffold.	 	 HNPCs	 within	 the	 scaffold	 materials	 were	 also	 shown	 to	 retain	
expression	 of	 the	 protein	 vimentin,	 indicative	 of	 the	materials	 supporting	 the	 viable	 culture	 of	
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